Q2 13F filings show that billionaire Ken Fisher's Fisher Asset Management opened new positions in CRISPR Therapeutics (NASDAQ: CRSP) and Coinbase Global (NASDAQ: COIN). Fisher's fund bought 77,960 C… [+2647 chars]
No comments yet. Be the first to comment!